Fujifilm Holdings (TSE:4901) agreed to drop nearly $1 billion in cash on SonoSite (NSDQ: SONO) in a $54-per-share offer.
The roughly $995 million bid has been approved by both companies’ boards, according to a press release.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Baxter International Inc. (NYSE:BAX) agreed to pony up $28 per share, or $325 million, for Synovis Life Technologies, Inc. (NSDQ:SYNO) and its lines of soft tissue repair and microsurgery products.
News of the deal sent SYNO shares up nearly 49 percent to $27.78 from yesterday’s close. BAX shares ticked up 0.3 percent to $49.93 as of about noon today.
Baxter International Inc. (NYSE:BAX) agreed to pony up $28 per share, or $325 million, for Synovis Life Technologies, Inc. (NSDQ:SYNO) and its lines of soft tissue repair and microsurgery products.
News of the deal sent SYNO shares up nearly 49 percent to $27.78 from yesterday’s close. BAX shares ticked up 0.3 percent to $49.93 as of about noon today.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Orthopedic company Symmetry Medical (NYSE:SMA) signed a definitive agreement to acquire the surgical instrument business of Johnson & Johnson (NYSE:JNJ) subsidiary Codman & Shurtleff for $165 million cash.
Symmetry plans to integrate its current hospital direct business, Specialty Surgical Instrumentation, with Codman’s line of surgical instruments.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
An FDA advisory panel decided that CardioMEMS failed to prove that its wireless, implantable heart monitor’s benefits outweigh its risks, casting a shadow on a potential $375 million acquisition by St. Jude Medical (NYSE:STJ) – which already owns nearly a fifth of CardioMEMS.
The U.S. Internal Revenue Service hit Boston Scientific (NYSE:BSX) with another huge tax bill over its 2006 acquisition of pacemaker firm Guidant Corp.
The latest tab, for $581 million plus interest and penalties, comes out of an IRS audit of Guidant’s books for 2004 through 2006, according to a regulatory filing.
Teleflex Inc. (NYSE:TFX) completed the $280 million sale of its aerospace business to a subsidiary of AAR Corp. (NYSE:AIR) as it takes steps toward becoming a pure-play medical device maker.
"Since 2007, we have been executing a strategy to transform Teleflex from a cyclical, diversified-industrial conglomerate into a pure-play medical technology company," president & CEO Benson Smith said in prepared remarks.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.